Skip to main content

GILEAD SCIENCES INC

For the period ended Dec 31, 2023. Filed Feb 23, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 23, 2024

GILD$170.87+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Comprehensive Income

Year Ended December 31,
(in millions)202320222021
Net income:$5,613$4,566$6,201
Other comprehensive income (loss), net:
Net foreign currency translation gain (loss)60(11)(38)
Available-for-sale debt securities:
Net unrealized gain (loss), net of tax impact of $0, $0 and $(1), respectively26(30)(6)
Reclassifications to net income, net of tax impact of $0, $0 and $0, respectively21—
Net change28(29)(6)
Cash flow hedges:
Net unrealized (loss) gain, net of tax impact of $(2), $20 and $18, respectively(12)130129
Reclassifications to net income, net of tax impact of $7, $25 and $(9), respectively(51)(171)58
Net change(62)(41)187
Other comprehensive income (loss), net26(81)143
Comprehensive income, net5,6394,4856,344
Comprehensive loss attributable to noncontrolling interest, net522624
Comprehensive income attributable to Gilead, net$5,691$4,511$6,368
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.